Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder

Completed · Phase 4

Conditions studied: Obsessive-compulsive Disorder

In brief

A 12-week program to examine the effectiveness of topiramate in adjunctive treatment for adults with obsessive-compulsive disorder and who are currently on serotonin reuptake inhibitor medications (ages 18-65).

Key facts

Study ID

NCT00211744

Run by

Montefiore Medical Center

People needed

24

Starts

2004-08-01

Expected to finish

2006-08-01

Last updated by the study team

2018-05-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and Females 18-65 years of age diagnosed with OCD and currently taking SSRI medication(s)

You may not qualify if…

• major medical disorders

Where it is running

• Mount Sinai School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.